对利福平的敏感性：发生率、机制及预防
Sensitivity to rifampicin: incidence, mechanism, and prevention.
作者信息
Pujet J C, Homberg J C, Decroix G
出版信息
Br Med J. 1974 May 25;2(5916):415-8. doi: 10.1136/bmj.2.5916.415.
Abstract
Five out of 200 patients taking rifampicin 900 mg twice weekly and three out of 91 patients taking rifampicin who attended an immunology clinic developed intolerance to the drug. Antibodies to rifampicin, which were found in most cases, decreased steadily after the end of treatment but were detectable for up to 16 months. The dose of rifampicin and the blood levels are predominating factors in the occurrence of reactions. Thus the dose should be reduced in patients in whom rifampicin blood levels rise abnormally. When it is important to continue rifampicin treatment despite intolerance antibody titres within 24 hours after administration of the drug must be measured to find when they are lowest, which determines the "unreactive period," and when a further dose may be safely given.
摘要
200名每周两次服用900毫克利福平的患者中有5人，以及91名前往免疫诊所就诊的服用利福平的患者中有3人出现了药物不耐受情况。在大多数病例中发现的利福平抗体，在治疗结束后稳步下降，但在长达16个月的时间内仍可检测到。利福平的剂量和血药浓度是反应发生的主要因素。因此，利福平血药浓度异常升高的患者应减少剂量。当尽管存在不耐受情况但仍有必要继续使用利福平治疗时，必须在给药后24小时内测量抗体滴度，以确定其何时最低，即“无反应期”，以及何时可以安全地给予下一剂药物。
相似文献
1
Sensitivity to rifampicin: incidence, mechanism, and prevention.对利福平的敏感性：发生率、机制及预防
Br Med J. 1974 May 25;2(5916):415-8. doi: 10.1136/bmj.2.5916.415.
2
Relationship between rifampicin-dependent antibody scores, serum rifampicin concentrations and symptoms in patients with adverse reactions to intermittent rifampicin treatment.间歇性利福平治疗不良反应患者中利福平依赖性抗体评分、血清利福平浓度与症状之间的关系。
Clin Allergy. 1973 Dec;3(4):353-62. doi: 10.1111/j.1365-2222.1973.tb01342.x.
3
Lymphocyte transformation test for the evaluation of adverse effects of antituberculous drugs.用于评估抗结核药物不良反应的淋巴细胞转化试验。
Eur J Med Res. 1999 Feb 25;4(2):67-71.
4
[Rifampicin in the treatment of tuberculosis].
Duodecim. 1973;89(11):807-17.
5
Potentially serious side effects of high-dose twice-weekly rifampicin.高剂量每周两次利福平潜在的严重副作用。
Br Med J. 1971 Aug 7;3(5770):343-7. doi: 10.1136/bmj.3.5770.343.
6
Controlled trial of intermittent regimens of rifampicin plus isoniazid for pulmonary tuberculosis in Singapore.利福平加异烟肼间歇疗法治疗新加坡肺结核的对照试验。
Lancet. 1975 Dec 6;2(7945):1105-9.
7
[Immunological aspects of adverse reactions during treatment with rifampicin].
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol. 1981 Jan-Mar;30(1):33-7.
8
Rifampicin-dependent antibodies in twice-weekly treated patients.
Scand J Respir Dis Suppl. 1973;84:98-101.
9
[Liver tolerance of antitubercular treatment including rifampicin. Study on 214 cases].[包括利福平在内的抗结核治疗的肝脏耐受性。对214例患者的研究]
Sem Hop. 1973 Jun 26;49(30):2219-24.
10
Immunological and haematological investigations on patients with adverse reactions during treatment with RMP plus INH once-weekly.
Scand J Respir Dis Suppl. 1973;84:87-93.
引用本文的文献
1
Symptoms and Systemic Drug Reactions in Persons Receiving Weekly Rifapentine Plus Isoniazid (3HP) Treatment for Latent Tuberculosis Infection.接受利福喷丁加异烟肼（3HP）方案治疗潜伏性结核感染的患者的症状和全身药物反应。
Clin Infect Dis. 2023 Jun 16;76(12):2090-2097. doi: 10.1093/cid/ciad083.
2
Rifampin-Associated Flu-Like Syndrome in a Patient Undergoing Treatment for a Device-Related Infection.一名正在接受与器械相关感染治疗的患者出现的利福平相关类流感综合征。
Cureus. 2020 Dec 28;12(12):e12336. doi: 10.7759/cureus.12336.
3
Acute subdural hemorrhage associated with rifampicin-induced thrombocytopenia.利福平引起的血小板减少症相关的急性硬脑膜下血肿。
Neurol Sci. 2010 Apr;31(2):199-200. doi: 10.1007/s10072-009-0187-7. Epub 2009 Dec 4.
4
Avoidance and management of adverse reactions to antituberculosis drugs.抗结核药物不良反应的预防与处理
Drug Saf. 1995 Jan;12(1):1-25. doi: 10.2165/00002018-199512010-00001.
5
Rifampicin-induced thrombocytopenia.利福平诱导的血小板减少症。
Postgrad Med J. 1980 Jan;56(651):59-60. doi: 10.1136/pgmj.56.651.59.
6
Rifampicin-induced upper gastrointestinal bleeding.利福平诱发的上消化道出血。
Postgrad Med J. 1990 Apr;66(774):310-1. doi: 10.1136/pgmj.66.774.310.
7
Serologic studies on the occurrence of specific rifampicin antibodies during continuous rifampicin treatment--its frequency and significance.关于连续利福平治疗期间特异性利福平抗体出现情况的血清学研究——其频率及意义。
Pneumonologie. 1976 Apr 9;153(2):109-17. doi: 10.1007/BF02091432.
8
New drug regimens in the treatment of tuberculosis.治疗结核病的新药物疗法。
Bull N Y Acad Med. 1975 Oct;51(9):1096-1102.
本文引用的文献
1
[Study of an allergic antibody active in the presence of sodium p-aminosalicylate (PAS) against human erythrocytes, leukocytes and platelets].
Vox Sang. 1961 Jan;6:91-109. doi: 10.1111/j.1423-0410.1961.tb03139.x.
2
[Rifampicin: initial study of plasma levels during prolonged treatment of pulmonary tuberculosis patients].[利福平：肺结核患者长期治疗期间血浆水平的初步研究]
Rev Tuberc Pneumol (Paris). 1968 Dec;32(8):991-1006.
3
[Hemolytic crisis due to rifampicin].[利福平所致溶血性危机]
Prax Pneumol. 1971 Aug;25(8):466-8.
4
[Comparative study of the treatment of pulmonary tuberculosis by a combination of rifampicin and isoniazid administered daily and twice weekly for a year].
Rev Tuberc Pneumol (Paris). 1971 Jan-Feb;35(1):39-54.
5
Haemolytic anaemia in the rabbit following the injection of human anti-I cold agglutinins.注射人抗-I 冷凝集素后家兔发生的溶血性贫血。
Clin Exp Immunol. 1971 Jul;9(1):99-110.
6
Rifampicin-induced immune thrombocytopenia.利福平诱导的免疫性血小板减少症。
Br Med J. 1970 Jul 4;3(5713):24-6. doi: 10.1136/bmj.3.5713.24.
7
Potentially serious side effects of high-dose twice-weekly rifampicin.高剂量每周两次利福平潜在的严重副作用。
Br Med J. 1971 Aug 7;3(5770):343-7. doi: 10.1136/bmj.3.5770.343.
8
[Systemic collateral effects of intermittent antituberculous treatments with rifampicin].[利福平间歇性抗结核治疗的全身附带效应]
Rev Tuberc Pneumol (Paris). 1971 Nov;35(7):733-43.
9
[Recurrent hemolytic accidents of immuno-allergic origin during intermittent treatment with rifampicin].[利福平间歇治疗期间源于免疫过敏的复发性溶血事故]
Rev Tuberc Pneumol (Paris). 1972 Apr-May;36(3):405-16.
10
[Acute kidney failure due to rifampicin].利福平所致急性肾衰竭
Nouv Presse Med. 1973 Sep 15;2(32):2093-5.
Zotero 插件